Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters
#Novartis underline#Trump pharma#pharma tariff#Reuters Roche#tariff announcement
Life Science News
Latest updates from the biotech and pharma world
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC
#obesity player#Roche targets#experimental drug#drug enters#enters late-stage
Geriatrician Roche appointed Professor Emeritus of Internal Medicine - UT Southwestern Medical Center
#Professor Emeritus#Southwestern Medical#Internal Medicine#Medical Center#Geriatrician Roche
Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#myeloma target#Roche pushes#Pipeline Roche
Roche's 'top three' obesity ambition not reliant on developing one megablockbuster - Fierce Biotech
#Fierce Biotech#obesity ambition#Biotech Roche#megablockbuster Fierce#top
Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#Pipeline Roche#ApexOnco#analysis Oncology
Roche, muscling into weight-loss drug race, advances obesity treatment to late-stage trial - Reuters
#drug race#advances obesity#weight-loss drug#obesity treatment#Reuters Roche
Roche CEO, pharma execs to meet with Swiss government over US tariffs - Reuters
#Roche CEO#Swiss government#pharma execs#Reuters Roche#CEO
Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test - PR Newswire
#Moderate Complexity#Roche achieves#Newswire Roche#total test#CLIA
Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
#drug developer#acquire liver#liver drug#Reuters Roche#billion Reuters
Roche dives into MASH with $2.4B deal for 89bio - BioPharma Dive
#BioPharma Dive#Roche dives#Dive Roche#MASH#deal
Obituary information for Ellen Sue Roche - Gunderson Funeral Home
#Ellen Sue#Sue Roche#Gunderson Funeral#Funeral Home#Roche Gunderson
Foresight Diagnostics and Roche Enter Licensing Agreement for PhasED-Seq™ Technology in Non-Hodgkin's Lymphoma - PR Newswire
#Roche Enter#Enter Licensing#Licensing Agreement#Foresight Diagnostics#Non-Hodgkin Lymphoma
Roche begins building $700M obesity drug manufacturing facility in N.C. - Fierce Pharma
#begins building#obesity drug#Fierce Pharma#Roche begins#drug manufacturing
Oliver Roche - Men's Soccer - uclabruins.com
#Men Soccer#Oliver Roche#Roche#Men#Soccer uclabruins.com
Roche considering direct-to-patient sales in US to bypass intermediaries - FirstWord Pharma
5,000 patients later Roche scraps its TIGIT | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#Roche scraps#ApexOnco#analysis Oncology
Roche considering selling drugs directly to US patients, CEO says - Reuters
#selling drugs#drugs directly#Reuters Roche#CEO#patients
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub - PR Newswire
#Indianapolis diagnostics#Roche announces#million investment#diagnostics manufacturing#Newswire Roche